Designing a global monitoring system for pilot introduction of a new contraceptive technology, subcutaneous DMPA (DMPA-SC)
Autor: | Anna Stout, Daouda Siddo, Allen Namagembe, Siri Wood, Alain Kaboré, Ida Ndione |
---|---|
Rok vydání: | 2017 |
Předmět: |
Process management
Strategy and Management Data management Geography Planning and Development Product introduction Pilot Projects 0302 clinical medicine Information system Contraceptive Agents Female Uganda 030212 general & internal medicine Niger Program Development 030219 obstetrics & reproductive medicine Injectable contraception Stakeholder Pilot Health information systems (HIS) Senegal Product (business) Family planning DMPA-SC Adult Capacity Building Social Psychology Adolescent Injections Subcutaneous Developing country Medroxyprogesterone Acetate Article 03 medical and health sciences Young Adult Chart Burkina Faso Humans Indicators Sayana Press Business and International Management Africa South of the Sahara Contraceptive introduction Monitoring systems Data collection business.industry Public Health Environmental and Occupational Health Delayed-Action Preparations Africa Subcutaneous DMPA Business Program Evaluation |
Zdroj: | Evaluation and Program Planning |
ISSN: | 1873-7870 |
Popis: | Highlights • From 2014 to 2016, the MOHs of Burkina Faso, Niger, Senegal and Uganda launched pilot introductions of the novel injectable contraceptive DMPA-SC. • This manuscript describes a four-phase approach to monitoring DMPA-SC pilot introduction across the four countries. • Existing national family planning registers were used to monitor DMPA-SC pilot introductions, with modifications. • Comprehensive data from DMPA-SC pilot introduction informed decisions about future investments in the product and scaling product availability nationally. In collaboration with ministries of health, PATH and key partners launched the first pilot introductions of subcutaneous depot medroxyprogesterone acetate (DMPA-SC, brand name Sayana® Press) in Burkina Faso, Niger, Senegal, and Uganda from July 2014 through June 2016. While each country implemented a unique introduction strategy, all agreed to track a set of uniform indicators to chart the effect of introducing this new method across settings. Existing national health information systems (HIS) were unable to track new methods or delivery channels introduced for a pilot, thus were not a feasible source for project data. We successfully monitored the four-country pilot introductions by implementing a four-phase approach: 1) developing and defining global indicators, 2) integrating indicators into existing country data collection tools, 3) facilitating consistent reporting and data management, and 4) analyzing and interpreting data and sharing results. Project partners leveraged existing family planning registers to the extent possible, and introduced new or modified data collection and reporting tools to generate project-specific data where necessary. We routinely shared monitoring results with global and national stakeholders, informing decisions about future investments in the product and scale up of DMPA-SC nationwide. Our process and lessons learned may provide insights for countries planning to introduce DMPA-SC or other new contraceptive methods in settings where stakeholder expectations for measureable results for decision-making are high. |
Databáze: | OpenAIRE |
Externí odkaz: |